Risk of atrial fibrillation in patients with inflammatory bowel disease: A systematic review and meta-analysis

炎症性肠病患者发生房颤的风险:系统评价和荟萃分析

阅读:1

Abstract

BACKGROUND: Several studies have reported the association between inflammatory bowel disease (IBD) and the risk of atrial fibrillation (AF). This systematic review and meta-analysis aimed to determine the prevalence and incidence of AF in the IBD population. METHODS: We conducted a systematic search of the PubMed and Embase databases for relevant studies published up to February 2024. We used the random-effects model to pool the prevalence and incidence rates of AF among IBD patients. The subgroup analyses were performed according to the IBD type. RESULTS: A total of twenty-five studies were included. The pooled prevalence of AF among IBD patients was 6.23 % (95 % confidence interval [CI]: 4.99 %-7.47 %). The incidence rate of AF among IBD patients was 3.53 % (95 % CI: 0.57 %-6.48 %). The risk of developing AF in IBD patients was 1.45 times higher than that in the general population (risk ratio [RR]: 1.45, 95 % CI: 1.21-1.73). When comparing specific IBD types to the general population, the RR was 1.35 (95 % CI: 1.11-1.64) for CD and 1.17 (95 % CI: 1.11-1.23) for UC. CONCLUSIONS: Our findings suggest that IBD patients exhibit an increased risk of developing AF compared to the general population. CD patients have a higher AF incidence compared to UC patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。